MarketCapTrends
SNOA
Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare

Sonoma Pharmaceuticals Inc. Total Liabilities 2011–2025

Sonoma Pharmaceuticals Inc. annual/quarterly total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Sonoma Pharmaceuticals Inc. total liabilities for the quarter ending March 31, 2025 were 9.3M, a 7.89% increase year-over-year.
  • Sonoma Pharmaceuticals Inc. total liabilities for 2025 were 9.3M, a 7.89% increase from 2024.
  • Sonoma Pharmaceuticals Inc. total liabilities for 2024 were 8.6M, a 4.23% increase from 2023.
  • Sonoma Pharmaceuticals Inc. total liabilities for 2023 were 8.3M, a 18.66% decrease from 2022.
  • Sonoma Pharmaceuticals Inc. total liabilities for 2022 were 10.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Sonoma Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $)
2025$9
2024$9
2023$8
2022$10
2021$10
2020$9
2019$4
2018$4
2017$4
2016$4
2015$3
2014$9
2013$8
2012$9
2011$7
Sonoma Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $)
2025-03-31$9
2024-03-31$9
2023-03-31$8
2022-03-31$10
2021-03-31$10
2020-03-31$9
2019-03-31$4
2018-03-31$4
2017-03-31$4
2016-03-31$4
2015-03-31$3
2014-03-31$9
2013-03-31$8
2012-03-31$9
2011-03-31$7

Sonoma Pharmaceuticals Inc. Total Liabilities — FAQ

Sonoma Pharmaceuticals Inc. (SNOA) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see SNOA's total liabilities history?

The chart and table above show Sonoma Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.